Condition: Glaucoma · Ocular Hypertension · Sponsor: Rigshospitalet, Denmark
a randomized, investigator-blind, interventinal study will compare the effect of benzalkonium-chloride (BAK) preserved and preservative-free (PF) eye drops on conjunctival goblet cells.
This description comes directly from the study's public registry record.
Anne Nagstrup, MD · +4522334504 · anne.hedengran.nagstrup@regionh.dk
Miriam Kolko, MD, PhD · miriamk@sund.ku.dk
Always discuss trial participation with your own doctor first.
| Department of ophthalmology, rigshospitalet.glostrup | Glostrup Municipality, Danmark, Denmark | Not Yet Recruiting |
| Department of drug design and pharmacology, University of Copenhagen | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04957329